Information Letter on Sabril®: MRI findings reveal brain anomalies and motion disorders
2010.10.29
Active substance: vigabatrine
During the ongoing safety monitoring of Sabril® (vigabatrine), case reports on MRI findings of brain anomalies and motion disorders were analysed.
A Rote-Hand-Brief is being sent out together with the
(summary of product characteristics).
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN